Figure 4
Figure 4. Pharmacokinetic profile of MS-275. Data were obtained from 35 patients with leukemia treated with MS-275 at dose levels ranging from 4 to 10 mg/m2. (A) Concentration-time profiles of MS-275 administered orally by dose group. Data from patients treated at the same dose levels were grouped and are presented as mean values (symbol) ± SE (error bar). The legend insert shows the different symbols/lines used for each of the test dose levels. (B) Effect of drug dose on the area under the plasma concentration versus time curve of MS-275 (AUC). Each symbol represents data from an individual patient, and horizontal lines represent the median value in each dose group.

Pharmacokinetic profile of MS-275. Data were obtained from 35 patients with leukemia treated with MS-275 at dose levels ranging from 4 to 10 mg/m2. (A) Concentration-time profiles of MS-275 administered orally by dose group. Data from patients treated at the same dose levels were grouped and are presented as mean values (symbol) ± SE (error bar). The legend insert shows the different symbols/lines used for each of the test dose levels. (B) Effect of drug dose on the area under the plasma concentration versus time curve of MS-275 (AUC). Each symbol represents data from an individual patient, and horizontal lines represent the median value in each dose group.

Close Modal

or Create an Account

Close Modal
Close Modal